How much funding has Aspira Women's Health raised?

Aspira Women's Health has disclosed $25.2M raised across 6 rounds.

Where is Aspira Women's Health headquartered?

Aspira Women's Health is headquartered in Austin, US.

Aspira Women's Health

OTC: AWHL

Austin, US · Founded 1993 · Delaware corporation · 58 employees on LinkedIn

Find your way into Aspira Women's Health

426 people in our graph can introduce you to the Aspira Women's Health team.

Paths you didn't know you had: your email and LinkedIn already hold routes to the Aspira Women's Health team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aspira Women's Health develops and commercializes blood-based diagnostic tests using artificial intelligence and multiple biomarkers to help assess the risk of ovarian cancer and other gynecologic diseases in women. The company operates a CLIA-certified laboratory in Texas and distributes its tests—including Ova1Plus and OvaWatch—through a direct sales force and channel partnerships with laboratory providers.

Biotech Healthtech

Founders & leadership

Sandra MilliganPresident

Nicole Sandford President and CEO, Board Member2022–2024Nicole Sandford served as President and CEO of Aspira Women's Health and previously held leadership roles at Deloitte, where she spent nearly three decades as an audit partner and led consulting businesses in financial services, life sciences, and consumer products.

Robert BeecheyExecutive

Valerie B. Palmieri Executive Chairwoman2022–2023Valerie Palmieri is an executive leader with experience in biotech companies, where she has held roles including CEO and board positions overseeing sales, operations, research, compliance, and finance functions. She served as Executive Chairwoman, President, and CEO of Aspira Women's Health, where she expanded the company's diagnostic portfolio and integrated artificial intelligence and machine learning into its offerings for gynecologic health assessment.

Michael Buhle Chief Executive OfficerHe has held leadership roles across healthcare technology, diagnostics, and life sciences companies, with experience in business development, operations, and clinical markets including oncology and genomic medicine.

Brian Hungerford Chief Financial Officer2025–2026Brian Hungerford is Chief Financial Officer at Aspira Women's Health, bringing over 20 years of experience in accounting, finance, technical accounting, financial reporting, internal controls, mergers and acquisitions, and systems implementation across multiple industries.

Board

Winfred ParnellBoard director

Stefanie Cavanaugh Board Member, Compensation Committee Chair2023–2025Executive Officer at Apollo Endosurgery

Celeste FralickBoard director

Ellen O'Connor VosBoard director

Jannie HerchukBoard director

Veronica G. H. JordanBoard director

Reported raises · per SEC filings

Form D private placements

$25.2M disclosed across 6 rounds · 2020–2026

▶$1.5MraisedJun 2026 · 19 investors · Biotechnology

Rule 506(b)